Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
which may result in inhibition of tumor cell growth and survival in susceptible tumor cell populations
Willardsen JA
Solubility: DMSO 85 mg/mL (200
This results in an induction of the synthesis of certain anti-inflammatory proteins while inhibiting the synthesis of certain inflammatory mediators
Formula: C13H8N6
Icotinib Hydrochloride - CAS# 1204313-51-8 Size:Solid 10 mg which may result in inhibitionIcotinib, also known as BPI 2009, is an orally available quinazoline based inhibitor of epidermal growth factor receptor (EGFR), with potential antineoplastic activity. Icotinib selectively inhibits the wild type and several mutated forms of EGFR tyrosine kinase. This may lead to an inhibition of EGFR mediated signal transduction and may inhibit cancer cell proliferation. EGFR, a receptor tyrosine kinase, is upregulated in a variety of cancer cell
US$ 27.00
US$ 27.00
US$ 27.00
US$ 27.00
US$ 11.99
US$ 27.00
US$ 12.99
US$ 20.00
US$ 19.99
US$ 27.00